Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Hemodialysis on Plasma Carnitine Levels in ESRD
NCT05817799Phase 3Completed
- Sponsor
- Bahria University
- Start
- Jan 2023
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of levocarnitine in carnitine deficiency (2 arms), sponsored by Bahria University. Primary endpoint: Plasma L-Carnitine levels at 5 months. Started Jan 2023; status: completed.
02
Drugs
levocarnitine
03
Conditions
carnitine deficiency
Beyond the preview
Go deeper on NCT05817799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05817799.